Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.
Cancer is a complex disease that involves the accumulation of both genetic and epigenetic alterations of numerous genes. Data in the Genetic Alterations in Cancer database for gene mutations and allelic loss [loss of heterozygosity (LOH)] in human tumors (e.g. lung, oral, esophagus, stomach and colon/rectum) were reviewed. Results for the genes and pathways implicated in tumor development at these sites are presented. Mutation incidence, spectra and codon specificity are described for lung, larynx and oral tumors. LOH occurred more frequently than gene mutations in tumors from all sites examined. The cell cycle gene, TP53 (all sites), and cell signaling gene, APC (colorectal and gastric cancers), were the only genes with similar incidences of LOH and mutation. Alterations of one or more cell cycle and cell signaling genes were reported for tumors from each site. Site-specific activation was apparent in the cell signaling mitogen-activated protein kinase oncogenes (KRAS in lung, HRAS in oral cancers and BRAF in esophageal and colorectal cancers). Analysis of genetic changes in lung tumors showed that the incidence of mutations in the TP53 and KRAS genes and the incidence of LOH in the FHIT gene were significantly greater in smokers versus non-smokers (P < 0.01). In lung and oral cancers, the TP53 GC --> TA transversion frequency increased with tobacco smoke exposure (P < 0.05). Furthermore, the TP53 mutational hot spots for lung and laryngeal cancers from smokers included codons 157, 245 and 273, whereas for oral tumors included codons 280 and 281.
Lea
I A
IA
Integrated Laboratory Systems, Inc., Research Triangle Park, NC 27709, USA. ilea@ils-inc.com
Jackson
M A
MA
Li
X
X
Bailey
S
S
Peddada
S D
SD
Dunnick
J K
JK
D002453:Cell Cycle / Q000235:genetics; D015179:Colorectal Neoplasms / Q000235:genetics; D004938:Esophageal Neoplasms / Q000235:genetics; D016368:Frameshift Mutation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D019656:Loss of Heterozygosity; D008175:Lung Neoplasms / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D017354:Point Mutation; D015398:Signal Transduction / Q000235:genetics; D013274:Stomach Neoplasms / Q000235:genetics
Eur J Cancer Prev. 2000 Apr;9(2):113-8
10830578
Cancer Res. 1994 Sep 15;54(18):4855-78
8069852
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302
10207632
Environ Health Perspect. 1996 May;104 Suppl 3:553-6
8781382
J Pathol. 1999 Jan;187(1):8-18
10341702
Science. 1996 Oct 18;274(5286):430-2
8832894
Cancer Res. 1996 Sep 1;56(17):3975-9
8752166
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3416-21
11248093
Carcinogenesis. 1993 Aug;14(8):1603-8
8353844
Environ Health Perspect. 1998 Jul;106(7):385-91
9637795
Mol Carcinog. 1993;8(3):186-92
8216737
Mutagenesis. 2001 Nov;16(6):551-3; author reply 555-6
11682648
Carcinogenesis. 1995 Oct;16(10):2487-92
7586156
Carcinogenesis. 1997 Mar;18(3):473-8
9067544
Carcinogenesis. 1993 Nov;14(11):2419-22
7902220
J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
10413421
Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13
11479891
Oncogene. 2004 Dec 2;23(56):9102-10
15489891
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):897-901
16702367
Respir Res. 2003;4:12
14641911
J Public Health Policy. 2006;27(1):61-76
16681188
Carcinogenesis. 2001 Mar;22(3):367-74
11238174
Br J Cancer. 2004 Dec 13;91(12):1983-9
15599380
Am J Ind Med. 1999 Oct;36(4):405-14
10470005
Nature. 2007 Mar 8;446(7132):153-8
17344846
Lancet. 2005 Nov 19;366(9499):1784-93
16298215
J Natl Cancer Inst. 2000 May 17;92(10):803-11
10814675
Am J Epidemiol. 2007 Aug 15;166(4):479-89
17548786
Cancer Res. 1991 Jul 1;51(13):3617-20
2054797
Science. 2006 Oct 13;314(5797):268-74
16959974
Br J Cancer. 1991 Apr;63(4):573-8
2021541
Exp Lung Res. 2001 Apr-May;27(3):245-53
11293327
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15404-9
17030796
Mol Med Today. 1996 Jan;2(1):32-7
8796849
Oncogene. 1998 Mar 12;16(10):1241-7
9546425
Cancer Res. 2005 Jun 15;65(12):5076-83
15958551
Clin Cancer Res. 2005 Apr 1;11(7):2502-9
15814626
Carcinogenesis. 1994 Sep;15(9):2031-5
7923598
Toxicol Sci. 2006 Apr;90(2):400-18
16410370
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
15285078
J Clin Oncol. 2000 Jun;18(11):2309-15
10829052
Cancer. 1993 Jul 15;72(2):432-8
8319174
Cancer Res. 1997 Jun 1;57(11):2256-67
9187130
Oncogene. 2002 Oct 21;21(48):7421-34
12379883
Br Med J. 1954 Jun 26;1(4877):1451-5
13160495
Mutat Res. 2004 Nov;567(2-3):427-45
15572289
Am J Public Health. 1999 Jul;89(7):1009-17
10394308
Jpn J Cancer Res. 1996 Jan;87(1):44-50
8609047
Int J Epidemiol. 2004 Dec;33(6):1183-4
15522923
Mutat Res. 1999 Jul 16;428(1-2):23-32
10517975